Applied DNA Sciences (NASDAQ:APDN) Coverage Initiated by Analysts at

Equities research analysts at assumed coverage on shares of Applied DNA Sciences (NASDAQ:APDNGet Free Report) in a research note issued to investors on Friday. The firm set a “hold” rating on the technology company’s stock.

Separately, HC Wainwright upped their target price on Applied DNA Sciences from $1.50 to $7.00 and gave the stock a “buy” rating in a research note on Monday, May 13th.

Check Out Our Latest Report on Applied DNA Sciences

Applied DNA Sciences Stock Performance

NASDAQ:APDN opened at $0.61 on Friday. The firm’s fifty day moving average is $5.21 and its two-hundred day moving average is $10.45. The firm has a market cap of $592,900.00, a price-to-earnings ratio of -0.04 and a beta of 0.26. Applied DNA Sciences has a one year low of $0.56 and a one year high of $37.20.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Applied DNA Sciences stock. Silverberg Bernstein Capital Management LLC bought a new stake in Applied DNA Sciences, Inc. (NASDAQ:APDNFree Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 98,301 shares of the technology company’s stock, valued at approximately $61,000. Silverberg Bernstein Capital Management LLC owned 0.72% of Applied DNA Sciences as of its most recent SEC filing. Hedge funds and other institutional investors own 22.22% of the company’s stock.

About Applied DNA Sciences

(Get Free Report)

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.

Featured Articles

Receive News & Ratings for Applied DNA Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences and related companies with's FREE daily email newsletter.